View Single Post
Old 12-20-2013, 08:17 AM
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
Default

Quote:
Originally Posted by Tupelo3 View Post
Developing and winning regulatory approval for new medicines can now take as long as it takes to raise a child to adulthood. But, can we make the FDA’s standards flexible enough to allow vital new drugs onto the market in a timely fashion, yet strict enough to protect us from potentially dangerous medicines?

Sidney Wolfe of Public Citizen’s Health Research Group and Kenneth Kaitin, a professor at the Tufts University School of Medicine look at challenges of developing — and approving — new medicines.....

.........The approval process for drugs is heavily tilted toward establishing evidence of benefit, but statistically underpowered to detect all but the most commonly occurring harms. Consequently, a number of new drugs have been withdrawn when dangerous, sometimes fatal, side effects are discovered, often within their first seven years after release. Also, serious new adverse reactions or drug interactions that require stronger warnings are usually detected within the first seven years after a drug’s release.

http://cognoscenti.wbur.org/2013/12/...kenneth-kaitin
there's the regulatory side and then there's the economic side, not going to get into the patent protection games, etc. but wow, drug companies are laying off employees and consolidating like mad and snapping up biotechs that are into cancer treatments, rare diseases etc. because of the money to be made because of the orphan drug act and cancer. something not quite right there.

as far as pd, who would have thought that l-dopa would still be the most effective drug treatment after 40 years? who would have thought that after the success of fetal transplants in the late 20years ago(?) - maybe there were some in the early 2000's? we still would have no disease altering treatment yet, at least 6 with gene therapy or growth factor infusions all having terrific phase1 results and failing in phase2? the more informed we are, logically the better informed we can require our representatives to be, our doctors to be and so on on these issues. so thanks for your posts tupelo3!!

then even with good old dependable carbidopa/levodopa, there are only a few manufacturers and there is always the threat they can play games with supply and demand if the govt ever tries to regulate prices happened in canada and england, not sure if there any CL is manufactured in the U.S. anymore.

hope for the best but plan for the worst, try to have at least a month's worth of drugs on hand, natural disasters happen and there's no govt stockpile of drugs.

Last edited by soccertese; 12-20-2013 at 08:18 AM. Reason: typos
soccertese is offline   Reply With QuoteReply With Quote